Skip to main content
SprintRay has launched the Midas World Tour across 30+ global cities to scale adoption of chairside 3D-printed restorations.
Expansion
1 min read

SprintRay has launched the Midas World Tour across 30+ global cities to scale adoption of chairside 3D-printed restorations.

SprintRay
SprintRay

Hardware

Originally reported by dental-tribune.com

SprintRay has launched the Midas World Tour across 30+ global cities to scale adoption of chairside 3D-printed restorations. In partnership with Align Technology and GC America, the workflow enables definitive restorations in under 30 minutes using the Midas Digital Press. This initiative provides 7 CE credits and marks a systemic shift from subtractive milling to high-viscosity additive manufacturing for permanent prosthetics. By unifying scanning and AI, SprintRay is setting a new standard for single-visit patient care. 🚀 #3DPrinting #DigitalDentistry #AM #SprintRay

How This Connects

6 related events
  1. Same pattern

    3D Systems secures full-scope EU MDR certification for NextDent Jetted Denture Solution

  2. Same pattern

    Cairn Surgical has submitted a De Novo 510(k) application to the FDA for its Breast Cancer Locator (BCL) System, a patient-specific 3D printed surgical guide.

  3. Same pattern

    Align Technology is transitioning from indirect to direct 3D printing for its Invisalign aligner production, moving away from the traditional process of printing molds for vacuum-forming.

  4. This article

    SprintRay has launched the Midas World Tour across 30+ global cities to scale adoption of chairside 3D-printed restorations.

  5. Same pattern

    Lithoz is launching three high-performance ceramic materials - LithaLox, LithaCon zirconia, and LithaCon ATZ - engineered for industrial serial production.

  6. Same pattern

    UnionTech is scaling specialized medical additive manufacturing across dentistry, orthopedics, and surgical planning.

  7. Same pattern

    Graphy is scaling its US presence by partnering with Benco Dental, reaching 23% of clinics, and building a Florida production facility.